share_log

Pfizer | SC TO-C: Written communication relating to an issuer or third party tender offer

Pfizer | SC TO-C: Written communication relating to an issuer or third party tender offer

輝瑞 | SC TO-C:投標報價書面通信
美股SEC公告 ·  08/01 18:08

Moomoo AI 已提取核心訊息

Pfizer Inc. has announced a voluntary Modification Offer for eligible employees holding certain equity awards, specifically the Five-Year Total Shareholder Return Units (TSRUs) and Performance Share Awards (PSAs) granted in 2022 and 2023. The offer, which is not yet commenced, aims to modify these awards to enhance their retention and motivational value in light of the company's stock price decline post-COVID-19 pandemic highs. The modification includes extending the performance and vesting periods by two years, among other changes. Eligible participants will have from August 12, 2024, to September 12, 2024, to accept the offer, with the ability to change their election until the expiration time. Pfizer plans to file a Tender Offer Statement with the SEC and will provide the Modification Offer and related materials through the Fidelity NetBenefits online portal, the company's website, and the SEC's website. The company encourages eligible employees to consult with their tax and financial advisors before participating in the offer.
Pfizer Inc. has announced a voluntary Modification Offer for eligible employees holding certain equity awards, specifically the Five-Year Total Shareholder Return Units (TSRUs) and Performance Share Awards (PSAs) granted in 2022 and 2023. The offer, which is not yet commenced, aims to modify these awards to enhance their retention and motivational value in light of the company's stock price decline post-COVID-19 pandemic highs. The modification includes extending the performance and vesting periods by two years, among other changes. Eligible participants will have from August 12, 2024, to September 12, 2024, to accept the offer, with the ability to change their election until the expiration time. Pfizer plans to file a Tender Offer Statement with the SEC and will provide the Modification Offer and related materials through the Fidelity NetBenefits online portal, the company's website, and the SEC's website. The company encourages eligible employees to consult with their tax and financial advisors before participating in the offer.
輝瑞公司已宣佈對持有2022年和2023年授予的五年總股東回報單位(TSRUs)和業績股份獎勵(PSAs)的符合條件的員工進行自願修改。該計劃還未開始,旨在修改這些獎勵以增強它們在公司COVID-19疫情後的股價下跌的背景下的保留和激勵價值。修改包括將業績和歸屬期延長兩年等。符合條件的參與者將有從2024年8月12日到2024年9月12日的時間接受該計劃,並在到期時間前更改選項。輝瑞計劃向美國證券交易委員會(SEC)提交一份收購要約申明書,並通過Fidelity NetBenefits在線門戶、公司網站和SEC網站提供修改計券和相關材料。公司鼓勵符合條件的員工在參與計劃之前諮詢他們的稅務和財務顧問。
輝瑞公司已宣佈對持有2022年和2023年授予的五年總股東回報單位(TSRUs)和業績股份獎勵(PSAs)的符合條件的員工進行自願修改。該計劃還未開始,旨在修改這些獎勵以增強它們在公司COVID-19疫情後的股價下跌的背景下的保留和激勵價值。修改包括將業績和歸屬期延長兩年等。符合條件的參與者將有從2024年8月12日到2024年9月12日的時間接受該計劃,並在到期時間前更改選項。輝瑞計劃向美國證券交易委員會(SEC)提交一份收購要約申明書,並通過Fidelity NetBenefits在線門戶、公司網站和SEC網站提供修改計券和相關材料。公司鼓勵符合條件的員工在參與計劃之前諮詢他們的稅務和財務顧問。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息